Edwards Lifesciences Corporation (EW) vs GE HealthCare Technologies Inc. (GEHC)
A side-by-side comparison of Edwards Lifesciences Corporation and GE HealthCare Technologies Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of August 13, 2026. Differences are shown without an overall score or investment verdict.
EW
Edwards Lifesciences Corporation
$92.56HealthcareDelayed quote: Aug 13, 2026, 4:00 PM EDT
GEHC
GE HealthCare Technologies Inc.
$73.79HealthcareDelayed quote: Aug 13, 2026, 4:00 PM EDT
Total return — EW vs GEHC
growth of $100 · dividends reinvested · last 4yEW +28.2% (+6.4%/yr)GEHC +21.2% (+4.9%/yr)EW compounded faster over this window
EW GEHC
EW vs GEHC: by the numbers
- •EW is the larger company ($53.30B vs $33.33B market cap).
- •GEHC trades at the lower trailing earnings multiple (20.95 vs 53.48 P/E), one valuation lens rather than an overall verdict.
- •EW converts more revenue to profit (15.43% vs 7.86% net margin).
- •EW grew revenue faster over the past five years (5.75% vs 3.74% CAGR).
- •GEHC pays a dividend (0.19% yield), while EW has no payments in the available dividend history.
Metrics side by side
Valuation
| Metric | EW | GEHC |
|---|---|---|
| P/E ratio | 53.48 | 20.95 |
| Forward P/E | 31.01 | 14.69 |
| P/S ratio | 8.25 | 1.62 |
| P/B ratio | 5.06 | 2.99 |
| EV / EBITDA | 25.84 | 11.40 |
| FCF yield | 2.67% | 2.73% |
Profitability
| Metric | EW | GEHC |
|---|---|---|
| Gross margin | 77.98% | 42.90% |
| Operating margin | 28.09% | 12.70% |
| Net margin | 15.43% | 7.86% |
| ROE | 9.46% | 14.51% |
| ROIC | 11.40% | 8.84% |
Dividends
| Metric | EW | GEHC |
|---|---|---|
| Dividend yield | N/A | 0.19% |
| Payout ratio | N/A | 3.07% |
Growth (annualized)
| Metric | EW | GEHC |
|---|---|---|
| Revenue CAGR (5Y) | 5.75% | 3.74% |
| EPS CAGR (5Y) | 6.87% | 0.67% |
| FCF CAGR (5Y) | 6.41% | 1.07% |
| Total return CAGR (5Y) | -3.60% | N/A |
Frequently asked
- Which has the lower trailing P/E, EW or GEHC?
- GEHC has the lower trailing P/E: EW trades at 53.48 and GEHC at 20.95. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Which has grown faster, EW or GEHC?
- Over the past five years, EW grew revenue faster — EW at a 5.75% CAGR versus GEHC at 3.74%.
- Does EW or GEHC pay a bigger dividend?
- GEHC pays a dividend (0.19% yield), while EW has no payments in the available dividend history.
- Is EW or GEHC more profitable?
- EW runs the higher net margin — EW at 15.43% versus GEHC at 7.86%.
Go deeper
Dig into the metrics
Edwards Lifesciences P/E ratioGE HealthCare Technologies P/E ratioGE HealthCare Technologies dividend yieldEdwards Lifesciences ROEGE HealthCare Technologies ROEEdwards Lifesciences operating marginGE HealthCare Technologies operating marginEdwards Lifesciences revenue growthGE HealthCare Technologies revenue growthEdwards Lifesciences free cash flowGE HealthCare Technologies free cash flow
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified August 13, 2026.